Michael Robek

Dr. Robek is an Associate Professor at Albany Medical College and former Associate Professor at the Yale University School of Medicine, where he was a member of the Molecular Virology Program of the Yale Comprehensive Cancer Center, and a member of the Yale Liver Center. He has over twenty years of experience in virology and immunology research. After receiving his Ph.D. degree in Molecular Microbiology and Microbial Pathogenesis from Washington University in St. Louis, he carried out his postdoctoral research at The Scripps Research Institute, where he studied the immune response to hepatitis B virus (HBV). Dr. Robek has a broad background in virology, cytokines and vaccines. Over the past ten years, Dr. Robek’s research has been aimed at understanding how virus-host interactions might be therapeutically manipulated in new ways to control chronic virus infection, with an emphasis on HBV. The discoveries made by his lab have not only provided basic new insight into HBV replication and pathogenesis, but have also identified new potential targets for therapy. Dr. Robek is widely-recognized as an international authority on hepatitis viruses. He is author and co-author of over 30 scientific publications.